Results 21 to 30 of about 68,837 (213)

Analysis of new high-precision transit light curves of WASP-10 b: starspot occultations, small planetary radius, and high metallicity

, 2011
The WASP-10 planetary system is intriguing because different values of radius have been reported for its transiting exoplanet. The host star exhibits activity in terms of photometric variability, which is caused by the rotational modulation of the spots.
Baraffe, Berta, Boisse, Budaj, C. Adam, Carter, Christian, Claret, Czesla, Dittmann, Dittmann, Ducati, Désert, Eastman, Fortney, Fortney, G. Maciejewski, G. Nowak, Girardi, Hartman, Hubbard, Huber, Hébrard, Ikoma, Johnson, Johnson, Krejcová, Kundurthy, Leconte, M. Seeliger, Maciejewski, Mandel, N. Nettelmann, Nettelmann, Poddaný, Pollacco, Pont, Popper, R. Neuhäuser, Sanchis-Ojeda, Saumon, Saumon, Silva, Silva-Valio, Silva-Valio, Skrutskie, Smith, Southworth, Southworth, Southworth, Southworth, Southworth, Southworth, St. Raetz, Van Hamme, Winn, Wolter, Zacharias   +57 more
core   +1 more source

High-precision photometry of WASP-12 b transits

, 2011
The transiting extrasolar planet WASP-12 b was found to be one of the most intensely irradiated exoplanets. It is unexpectedly bloated and is losing mass that may accrete into the host star.
Agol, Campo, Chambers, Croll, Désert, Eastman, Fossati, Fossati, G. Maciejewski, Hebb, I. Spaleniak, Ibgui, Johnson, Lai, Li, López-Morales, M. Seeliger, Mandel, Miller, Miralda-Escudé, Poddaný, Popper, R. Errmann, R. Neuhäuser, Southworth, Southworth, Southworth, Southworth, Southworth, Southworth, Southworth, Southworth, St. Raetz, Van Hamme, Vidotto, Winn   +35 more
core   +1 more source

Transit timing variation and activity in the WASP-10 planetary system

, 2010
Transit timing analysis may be an effective method of discovering additional bodies in extrasolar systems which harbour transiting exoplanets. The deviations from the Keplerian motion, caused by mutual gravitational interactions between planets, are ...
A. Niedzielski, Agol, Alonso, Anglada-Escude, Antoja, Bakos, Baraffe, Baraffe, Barnes, Blaauw, Borucki, C. Marka, Chambers, Christian, Correia, Czesla, D. Dimitrov, Desort, Dias, Dittmann, Eastman, Everett, F. Walter, Fortney, G. Maciejewski, Gibson, H. Takahashi, Harding, Hatzes, Holman, J. Budaj, Johnson, Johnson, K. Tachihara, Kipping, Latham, Lendl, Lindblad, Lomb, M. Mugrauer, Maciejewski, Mandel, Mayor, Mermilliod, Meschiari, Miller-Ricci, Miralda-Escudé, Mugrauer, N. Tetzlaff, Nesvorný, Nesvorný, Niedzielski, Papaloizou, Poddaný, Pollacco, Poveda, R. Neuhäuser, S. Baar, Scargle, Schmidt-Kaler, Schneider, Schwarzenberg-Czerny, Smith, St. Raetz, T. Krejcová, Terndrup, Tetzlaff, Tetzlaff, V. Krushevska, Van Hamme, W. P. Chen, Wielen, Zacharias, Zahn, Zhao   +74 more
core   +1 more source

Transit timing variations in eccentric hierarchical triple exoplanetary systems. I. Perturbations on the time-scale of the orbital period of the perturber [PDF]

, 2010
We study the long-term time-scale (i.e. period comaprable to the orbital period of the outer perturber object) transit timing variations in transiting exoplanetary systems which contain a further, more distant (a_2>>a_1) either planetary, or stellar ...
Borkovits, Tamás, Csizmadia, Szilárd, Forgács-Dajka, Emese, Hegedüs, Tibor   +3 more
core   +2 more sources

Searching for Transit Timing Variations in Young Transiting Systems

The Astronomical Journal
The discovery of young (4 σ ), although differences in methodology make a totally fair comparison challenging. We show that spots have a weak-to-negligible impact on our results, and similarly cannot explain the higher TTV fraction.
Ana Isabel Lopez Murillo, Andrew W. Mann, Madyson G. Barber, Andrew Vanderburg, Pa Chia Thao, Andrew W. Boyle   +5 more
doaj   +1 more source

Practical suggestions on detecting exomoons in exoplanet transit light curves

, 2010
The number of known transiting exoplanets is rapidly increasing, which has recently inspired significant interest as to whether they can host a detectable moon. Although there has been no such example where the presence of a satellite was proven, several
Kiss, L. L., Regaly, Zs., Simon, A. E., Szabo, Gy. M.   +3 more
core   +1 more source

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population‐Based Report From CYP‐C

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.
Samuel Sassine, Ofélie Trudeau‐Ferrin, Caroline Laverdière, Patrick Hamel, Rosanne Superstein, Bénédicte Koukoui, Carole Provost, Paul C. Nathan, Vijay Ramaswamy, Furqan Shaikh, Brenda Gallie, Ashwin Mallipatna, Stephanie Kletke, Helen Dimaras, Hallie Coltin   +14 more
wiley   +1 more source

Doomed Worlds. II. Reassessing Suggestions of Orbital Decay for TrES-5 b

The Planetary Science Journal
TrES-5 b is one of only three ultrahot Jupiters with suggestions of a possibly decreasing orbital period that have persisted through multiple independent analyses.
Marvin Rothmeier, Elisabeth R. Adams, Karsten Schindler, André Beck, Brian Jackson, Jeffrey P. Morgenthaler, Amanda A. Sickafoose, Malia Barker, Luigi Mancini, John Southworth, Daniel Evans, Alfred Krabbe   +11 more
doaj   +1 more source

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács, Zoltán Köllő, Balázs Gellért Karvaly, Mahmoud Obeidat, Rita Nagy, Péter Hegyi, Brigitta Teutsch, Eszter Tuboly, Miklós Garami   +8 more
wiley   +1 more source